<Emphasis Type="Bold">Aims/hypothesis: To assess the cost-effectiveness of rosiglitazone in combination with other oral agents for the treatment of overweight and obese patients with type 2 diabetes in Germany. <Emphasis Type="Bold">Methods: The Diabetes Decision Analysis of Cost — type 2 model was adapted for clinical practice and...</emphasis></emphasis>